Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Cannon, Mary
Harley, Michelle
Clarke, Mary
and
Arseneault, Louise
2006.
Beyond Nature and Nurture in Psychiatry.
p.
141.
Hall, Wayne
and
Degenhardt, Louisa
2006.
What are the Policy Implications of the Evidence on Cannabis and Psychosis?.
The Canadian Journal of Psychiatry,
Vol. 51,
Issue. 9,
p.
566.
Degenhardt, Louisa
and
Hall, Wayne
2006.
Is Cannabis Use a Contributory Cause of Psychosis?.
The Canadian Journal of Psychiatry,
Vol. 51,
Issue. 9,
p.
556.
André, Charles
Jaber-Filho, Jorge A.
Bento, Rafael M.A.
Damasceno, Lúcia M.P.
and
Aquino-Neto, Francisco R.
2006.
Delirium Following Ingestion of Marijuana Present in Chocolate Cookies.
CNS Spectrums,
Vol. 11,
Issue. 4,
p.
262.
Hides, L.
Dawe, S.
Kavanagh, D. J.
and
Young, R. M.
2006.
Psychotic symptom and cannabis relapse in recent-onset
psychosis.
British Journal of Psychiatry,
Vol. 189,
Issue. 2,
p.
137.
Smesny, Stefan
Rosburg, Timm
Baur, Kati
Rudolph, Nicole
and
Sauer, Heinrich
2007.
Cannabinoids Influence Lipid–Arachidonic Acid Pathways in Schizophrenia.
Neuropsychopharmacology,
Vol. 32,
Issue. 10,
p.
2067.
Gründer, Gerhard
2007.
Pharmakotherapie therapieresistenter schizophrener Störungen.
Psychiatrie und Psychotherapie up2date,
Vol. 1,
Issue. 01,
p.
25.
Addington, J.
and
Addington, D.
2007.
Patterns, predictors and impact of substance use in early psychosis: a longitudinal study.
Acta Psychiatrica Scandinavica,
Vol. 115,
Issue. 4,
p.
304.
Boucher, A. A.
Arnold, J. C.
Duffy, L.
Schofield, P. R.
Micheau, J.
and
Karl, T.
2007.
Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Δ9-tetrahydrocannabinol.
Psychopharmacology,
Vol. 192,
Issue. 3,
p.
325.
Selten, Jean-Paul
Veen, Natalie D.
Hoek, Hans W.
Laan, Winfried
Schols, Diede
van der Tweel, Ingeborg
Feller, Wilma
and
Kahn, René S.
2007.
Early course of schizophrenia in a representative Dutch incidence cohort.
Schizophrenia Research,
Vol. 97,
Issue. 1-3,
p.
79.
Murray, Robin M.
Morrison, Paul D.
Henquet, Cécile
and
Forti, Marta Di
2007.
Cannabis, the mind and society: the hash realities.
Nature Reviews Neuroscience,
Vol. 8,
Issue. 11,
p.
885.
Caton, Carol L. M.
Hasin, Deborah S.
Shrout, Patrick E.
Drake, Robert E.
Domínguez, Boanerges
First, Michael B.
Samet, Sharon
and
Schanzer, Bella
2007.
Stability of early-phase primary psychotic disorders with
concurrent substance use and substance-induced psychosis.
British Journal of Psychiatry,
Vol. 190,
Issue. 2,
p.
105.
Flanders, Sarah E.
2007.
Delusions Incorporating Cannabis use in Dually Diagnosed Patients with a Primary Psychotic Disorder.
Australian & New Zealand Journal of Psychiatry,
Vol. 41,
Issue. 11,
p.
934.
Boydell, J.
Dean, K.
Dutta, R.
Giouroukou, E.
Fearon, P.
and
Murray, R.
2007.
A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: Implications for the concept of cannabis psychosis.
Schizophrenia Research,
Vol. 93,
Issue. 1-3,
p.
203.
Ringen, P. A.
Melle, I.
Birkenaes, A. B.
Engh, J. A.
Faerden, A.
Vaskinn, A.
Friis, S.
Opjordsmoen, S.
and
Andreassen, O. A.
2008.
The level of illicit drug use is related to symptoms and premorbid functioning in severe mental illness.
Acta Psychiatrica Scandinavica,
Vol. 118,
Issue. 4,
p.
297.
Wiley, Jenny L.
Kendler, Seth H.
Burston, James J.
Howard, Daniel R.
Selley, Dana E.
and
Sim-Selley, Laura J.
2008.
Antipsychotic-induced alterations in CB1 receptor-mediated G-protein signaling and in vivo pharmacology in rats.
Neuropharmacology,
Vol. 55,
Issue. 7,
p.
1183.
Harrison, I.
Joyce, E. M.
Mutsatsa, S. H.
Hutton, S. B.
Huddy, V.
Kapasi, M.
and
Barnes, T. R. E.
2008.
Naturalistic follow-up of co-morbid substance use in schizophrenia: the West London first-episode study.
Psychological Medicine,
Vol. 38,
Issue. 1,
p.
79.
Hjorthøj, Carsten
Fohlmann, Allan
Larsen, Anne-Mette
Madsen, Mette TR
Vesterager, Lone
Gluud, Christian
Arendt, Mikkel C
and
Nordentoft, Merete
2008.
Design paper: The CapOpus trial: A randomized, parallel-group, observer-blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis.
Trials,
Vol. 9,
Issue. 1,
Luzi, Sonija
Morrison, Paul D.
Powell, John
Di Forti, Marta
and
Murray, Robin M.
2008.
What is the mechanism whereby cannabis use increases risk of psychosis?.
Neurotoxicity Research,
Vol. 14,
Issue. 2-3,
p.
105.
HALL, WAYNE
and
DEGENHARDT, LOUISA
2008.
Cannabis use and the risk of developing a psychotic disorder.
World Psychiatry,
Vol. 7,
Issue. 2,
p.
68.
Comments
No Comments have been published for this article.